ImmuPharma plc (AIM:IMM)
London · Delayed Price · Currency is GBP · Price in GBX 10.00
+1.94 (24.08%)
Sep 9, 2025, 2:45 PM GMT+1
ImmuPharma Market Cap
ImmuPharma has a market cap or net worth of 40.28 million as of September 9, 2025. Its market cap has increased by 583.53% in one year.
Market Cap
40.28M
Enterprise Value
39.88M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
10.00
Market Cap Chart
Since February 22, 2006, ImmuPharma's market cap has increased from 36.11M to 40.28M, an increase of 11.53%. That is a compound annual growth rate of 0.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 8, 2025 | 40.28M | 702.65% |
| Dec 31, 2024 | 5.02M | -27.71% |
| Dec 29, 2023 | 6.94M | 13.16% |
| Dec 30, 2022 | 6.13M | -62.85% |
| Dec 31, 2021 | 16.51M | -50.56% |
| Dec 31, 2020 | 33.40M | 24.75% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 185.62B |
| GSK plc | 58.98B |
| Haleon | 32.14B |
| Smith & Nephew | 12.27B |
| ConvaTec Group | 4.86B |
| Hikma Pharmaceuticals | 3.76B |
| HUTCHMED (China) | 1.98B |
| Genus | 1.75B |